Dolby Laboratories, Inc. DLB Balance Sheet Statement
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| $673.81M-7.4% | $727.57M-8.3% | $793.36M+4.9% | $756.56M+0.8% | $750.34M+22.7% | ||
| $460K— | —— | —— | —— | —— | ||
| $640.44M+10.5% | $579.56M+11.6% | $519.22M+2.0% | $509.21M-7.6% | $551.09M-2.7% | ||
| $31.93M+2.1% | $31.26M+2.8% | $30.42M-6.1% | $32.42M-6.3% | $34.59M+8.7% | ||
| $1.41B+0.5% | $1.41B+1.4% | $1.39B+3.7% | $1.34B-3.7% | $1.39B+8.0% | ||
| $461.84M-1.0% | $466.72M-0.8% | $470.61M-1.6% | $478.48M+1.2% | $472.66M-0.7% | ||
| $529.67M-0.1% | $530.3M+0.1% | $529.9M+0.2% | $528.82M+0.7% | $525.02M+0.9% | ||
| $389.71M+7.1% | $364.02M-8.3% | $397.06M-2.7% | $408.15M-0.9% | $412.06M-2.2% | ||
| $81.22M-4.5% | $85.02M+6.0% | $80.21M+2.8% | $78.02M+5.8% | $73.76M-14.5% | ||
| $3.25B+1.8% | $3.19B-1.1% | $3.23B+1.0% | $3.2B-1.0% | $3.23B+2.2% | ||
| $20.69M+139% | $8.67M-51.4% | $17.84M+3.5% | $17.23M-0.3% | $17.29M+49.7% | ||
| $38.84M+4.7% | $37.09M+18.2% | $31.38M-12.9% | $36.03M-9.0% | $39.62M+6.7% | ||
| $474.61M+7.0% | $443.51M+1.3% | $437.79M+12.6% | $388.79M-15.0% | $457.49M+3.5% | ||
| $622.36M+5.6% | $589.25M-1.1% | $595.81M+2.4% | $581.75M-9.9% | $646.02M+0.7% | ||
| $2.63B+1.0% | $2.6B-1.2% | $2.63B+0.6% | $2.62B+0.6% | $2.6B+2.3% | ||
| $2.62B+0.9% | $2.59B-1.1% | $2.62B+0.7% | $2.6B+1.2% | $2.57B+2.6% | ||
| $3.25B+1.8% | $3.19B-1.1% | $3.23B+1.0% | $3.2B-1.0% | $3.23B+2.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Dolby Laboratories, Inc. cover its short-term obligations?
- Its current ratio is 2.98 — current assets exceed current liabilities.
- Where does Dolby Laboratories, Inc.'s balance sheet data come from?
- Every line is extracted from Dolby Laboratories, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.